Clinical Trial Results:
A multi-centre, randomized, controlled, single-blinded, phase II study to investigate the safety and efficacy of intravenous infusions of FERINJECT® versus placebo in patients with thrombocytosis secondary to iron deficiency and chronic inflammatory bowel disease
Summary
|
|
EudraCT number |
2006-003328-12 |
Trial protocol |
AT |
Global completion date |
31 Jan 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
08 Dec 2016
|
First version publication date |
08 Dec 2016
|
Other versions |
|
Summary report(s) |
ThromboVIT |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.